|
End-of-day quote
Ho Chi Minh S.E.
2026-09-30
|
5-day change | 1st Jan Change | ||
| 19,900.00 VND | -0.50% |
|
-0.50% | -2.99% |
| 09-11 | OPC Pharmaceutical Joint Stock Company Announces Change In Certificate Of Business Registration | CI |
| 08-17 | Opc Pharmaceutical Joint Stock Company Terminates Operations of Tien Giang Branch | CI |
Company Valuation: OPC Pharmaceutical
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 1,581,348 | 1,520,220 | 1,761,400 | 1,537,221 | 1,601,272 | 1,537,221 |
| Change | - | -3.87% | 15.86% | -12.73% | 4.17% | -4% |
| Enterprise Value (EV) 1 | 1,568,096 | 1,373,409 | 1,446,194 | 1,215,860 | 1,353,985 | 1,218,052 |
| Change | - | -12.42% | 5.3% | -15.93% | 11.36% | -10.04% |
| P/E | 15x | 12.1x | 13.8x | 14.7x | 17.6x | 15.6x |
| PBR | 2.45x | 2.23x | 2.18x | 1.87x | 1.97x | 1.69x |
| PEG | - | 0.6x | 8.41x | -0.8x | -1.3x | 1.89x |
| Capitalization / Revenue | 1.64x | 1.35x | 1.5x | 1.53x | 1.65x | 1.37x |
| EV / Revenue | 1.62x | 1.22x | 1.23x | 1.21x | 1.4x | 1.08x |
| EV / EBITDA | 9.92x | 7.26x | 7.18x | 7.19x | 8.64x | 7.92x |
| EV / EBIT | 11.5x | 8.24x | 8.1x | 8.32x | 10.1x | 9.21x |
| EV / FCF | 16x | 6.71x | 9.7x | 12.8x | 106x | 21.3x |
| FCF Yield | 6.26% | 14.9% | 10.3% | 7.78% | 0.94% | 4.7% |
| Dividend per Share 2 | 1,064 | - | 1,282 | 1,282 | - | 683.8 |
| Rate of return | 5.04% | - | 5.45% | 6.25% | - | 3.33% |
| EPS 2 | 1,408 | 1,682 | 1,709 | 1,397 | 1,214 | 1,314 |
| Distribution rate | 75.6% | - | 75% | 91.8% | - | 52% |
| Net sales 1 | 965,591 | 1,123,728 | 1,171,614 | 1,004,887 | 968,576 | 1,122,987 |
| EBITDA 1 | 158,152 | 189,215 | 201,454 | 169,015 | 156,652 | 153,844 |
| EBIT 1 | 136,411 | 166,713 | 178,636 | 146,120 | 134,434 | 132,289 |
| Net income 1 | 105,791 | 126,377 | 142,128 | 122,234 | 107,060 | 115,881 |
| Net Debt 1 | -13,252 | -146,811 | -315,205 | -321,361 | -247,287 | -319,169 |
| Reference price 2 | 21,101.54 | 20,285.85 | 23,504.27 | 20,512.82 | 21,367.52 | 20,512.82 |
| Nbr of stocks (in thousands) | 74,940 | 74,940 | 74,940 | 74,940 | 74,940 | 74,940 |
| Announcement Date | 3/15/21 | 3/7/22 | 3/15/23 | 3/22/24 | 3/27/25 | 3/23/26 |
1VND in Million2VND
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 57.71M | |
| 33.68x | 12.2x | 24.79x | 0.59% | 1,056B | |
| 29.76x | 6.61x | 18.5x | 2% | 645B | |
| 33.32x | 7.79x | 16.11x | 2.63% | 465B | |
| 108.6x | 6.05x | 25.67x | 2.29% | 368B | |
| 19.01x | 4.64x | 11.49x | 2.87% | 335B | |
| 20.51x | 5.32x | 13.17x | 3.01% | 275B | |
| 20.92x | 4.34x | 12.36x | 2.04% | 255B | |
| 26.76x | 6.95x | 12.37x | 2.38% | 229B | |
| -45.76x | 6.66x | 26x | 2.18% | 188B | |
| Average | 27.42x | 6.73x | 17.83x | 2.22% | 381.58B | |
| Weighted average by Cap. | 32.80x | 7.85x | 19.23x | 1.9% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- OPC Stock
- Valuation OPC Pharmaceutical
Select your edition
All financial news and data tailored to specific country editions
